Mark Thornton

Mark has acted as a consultant and scientific advisor to MMC since its inception and leads them on grant submissions and execution of the company’s microbiology protocol controls.

Has PhD in Cell Biology and Pharmacology from Imperial College London and MSc in cell & structural biology from University of Manchester. His professional experience spans lab-based scientific research, new product planning and corporate strategy.

Mark is an experienced senior executive who has held various roles in strategic development within the life sciences, biotechnology and pharmaceutical industry, including as Director of New Product Planning at Shionogi Inc and International Business Analyst at Roche.